Molecular Classification
Receptor-associated protein complex, Immunoglobulin superfamily, Signal transduction complex
Other Names
Cluster of differentiation 3, T3 complex, T cell co-receptor, CD3 antigen
Disease Roles
Cancer (lymphomas, leukemias)InfectionAutoimmune diseases

CD3 protein complex Overview

CD3 is a cell surface protein complex critical for T cell biology and immune signaling. It is composed of four subunits—CD3γ, CD3δ, CD3ε, and CD3ζ—arranged in dimers that associate noncovalently with the T cell receptor (TCR). The CD3 complex is essential for antigen recognition and transduction of activation signals following TCR stimulation via its immunoreceptor tyrosine-based activation motifs (ITAMs). CD3 is both a defining marker for T cell identification and an important target for monoclonal antibody therapeutics in cancer, transplant rejection, and autoimmune disorders. Safety concerns with CD3 targeting therapies include cytokine release syndrome and profound immunosuppression

Mechanism of Action

Antibody-mediated depletion of T cells (immunosuppression) Modulation of T cell activation Induction of T cell anergy or apoptosis Immunomodulation via ITAM phosphorylation and downstream signaling pathways

Biological Functions

Signal transduction
Immune response (adaptive immunity)
T cell activation
T cell lineage definition

Disease Associations

Cancer (lymphomas, leukemias)
Infection
Autoimmune diseases
Inflammatory diseases
Immunodeficiency syndromes

Safety Considerations

  • Cytokine release syndrome (CRS), especially with strong CD3 agonists
  • Immunosuppression and increased infection risk
  • Infusion reactions
  • Risk of autoimmunity or loss of self-tolerance

Interacting Drugs

Muromonab-CD3 (OKT3)
Teplizumab
Otelixizumab
Foralumab

Associated Biomarkers

Biomarker
CD3 immunohistochemistry (T cell lineage marker in tissue sections)
Flow cytometry (marker for enumeration of T cell populations)
Diagnostic marker in lymphoid malignancies and immune dysregulation